281 related articles for article (PubMed ID: 21687543)
1. NK cells and psoriasis.
Dunphy S; Gardiner CM
J Biomed Biotechnol; 2011; 2011():248317. PubMed ID: 21687543
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells.
Bonish B; Jullien D; Dutronc Y; Huang BB; Modlin R; Spada FM; Porcelli SA; Nickoloff BJ
J Immunol; 2000 Oct; 165(7):4076-85. PubMed ID: 11034419
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells from psoriasis vulgaris patients have reduced levels of cytotoxicity associated degranulation and cytokine production.
Dunphy SE; Sweeney CM; Kelly G; Tobin AM; Kirby B; Gardiner CM
Clin Immunol; 2017 Apr; 177():43-49. PubMed ID: 26477484
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis: dysregulation of innate immunity.
Bos JD; de Rie MA; Teunissen MB; Piskin G
Br J Dermatol; 2005 Jun; 152(6):1098-107. PubMed ID: 15948970
[TBL] [Abstract][Full Text] [Related]
5. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.
Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA
Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195
[TBL] [Abstract][Full Text] [Related]
6. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation.
Ottaviani C; Nasorri F; Bedini C; de Pità O; Girolomoni G; Cavani A
Eur J Immunol; 2006 Jan; 36(1):118-28. PubMed ID: 16323244
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association.
Duffin KC; Woodcock J; Krueger GG
Dermatol Ther; 2010; 23(2):101-13. PubMed ID: 20415816
[TBL] [Abstract][Full Text] [Related]
8. Immune responses and therapeutic options in psoriasis.
Afonina IS; Van Nuffel E; Beyaert R
Cell Mol Life Sci; 2021 Mar; 78(6):2709-2727. PubMed ID: 33386888
[TBL] [Abstract][Full Text] [Related]
9. The immunopathogenesis of psoriasis.
Kim J; Krueger JG
Dermatol Clin; 2015 Jan; 33(1):13-23. PubMed ID: 25412780
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in psoriasis.
Kastelan M; Prpić-Massari L; Brajac I
Acta Dermatovenerol Croat; 2009; 17(3):182-6. PubMed ID: 19818217
[TBL] [Abstract][Full Text] [Related]
11. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
Schafer PH; Parton A; Gandhi AK; Capone L; Adams M; Wu L; Bartlett JB; Loveland MA; Gilhar A; Cheung YF; Baillie GS; Houslay MD; Man HW; Muller GW; Stirling DI
Br J Pharmacol; 2010 Feb; 159(4):842-55. PubMed ID: 20050849
[TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis of psoriasis: focus on natural killer T cells.
Peternel S; Kastelan M
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1123-7. PubMed ID: 19453772
[TBL] [Abstract][Full Text] [Related]
13. IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation.
Zwicky P; Ingelfinger F; Silva de Melo BM; Ruchti F; Schärli S; Puertas N; Lutz M; Phan TS; Kündig TM; Levesque MP; Maul JT; Schlapbach C; LeibundGut-Landmann S; Mundt S; Becher B
Sci Immunol; 2021 Oct; 6(64):eabg9012. PubMed ID: 34678045
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.
de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK
Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323
[TBL] [Abstract][Full Text] [Related]
15. Natural killer and natural killer-T cells in psoriasis.
Cameron AL; Kirby B; Fei W; Griffiths CE
Arch Dermatol Res; 2002 Nov; 294(8):363-9. PubMed ID: 12420105
[TBL] [Abstract][Full Text] [Related]
16. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.
Lowes MA; Russell CB; Martin DA; Towne JE; Krueger JG
Trends Immunol; 2013 Apr; 34(4):174-81. PubMed ID: 23291100
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells in psoriasis.
Tobin AM; Lynch L; Kirby B; O'Farrelly C
J Innate Immun; 2011; 3(4):403-10. PubMed ID: 21613780
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system.
Nickoloff BJ; Bonish B; Huang BB; Porcelli SA
J Dermatol Sci; 2000 Dec; 24(3):212-25. PubMed ID: 11084303
[TBL] [Abstract][Full Text] [Related]
20. NK cells prevalence, subsets and function in viral hepatitis C.
Zeromski J; Mozer-Lisewska I; Kaczmarek M; Kowala-Piaskowska A; Sikora J
Arch Immunol Ther Exp (Warsz); 2011 Dec; 59(6):449-55. PubMed ID: 21972016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
